International
The Morning Science

What science found today

‹
 

Research

S100A16 drives hepatocellular carcinoma by promoting KCNJ8-mediated choline metabolic dysregulation and immunosuppression

Nature ·

The Brief

  • A Nature subject-feed item reports that S100A16 promotes hepatocellular carcinoma.
  • The reported mechanism involves KCNJ8-mediated choline metabolic dysregulation and immunosuppression.
  • The source provided no summary, so further experimental details are not available from the sources given.

Why it matters

It is a basic research finding on a possible mechanism in liver cancer, relevant to researchers studying tumour metabolism and immune evasion, but it has no established clinical consequence from the information provided.

Who’s affected

  • cancer and liver disease researchers
  • researchers studying tumour metabolism and tumour immunology

Timeline

  1. Article listed in Nature subject feed (Biological sciences)

  2. Biological sciences : nature.com subject feeds

    S100A16 drives hepatocellular carcinoma by promoting KCNJ8-mediated choline metabolic dysregulation and immunosuppression

How do you feel about this?

0 Comments

    S100A16 drives hepatocellular carcinoma by promoting KCNJ8-mediated choline metabolic dysregulation and immunosuppression – The Morning Science